A novel diagnostic model combining ProGRP and inflammatory biomarkers for early detection of lung cancer: development and validation in treatment-naive cohorts.
Pairing a specific protein marker with inflammation signals improves early lung cancer detection better than either approach works alone.
Researchers developed and validated a diagnostic model combining ProGRP with inflammatory biomarkers for early lung cancer detection. The model was tested in treatment-naive cohorts and showed improved diagnostic accuracy compared to individual markers.
What the study was
- Study design
- Retrospective diagnostic model development and validation
- Population
- Treatment-naive lung cancer patients
- Category
- Early Detection
- Maturity
- Validated
- Journal
- BMC cancer
Why it surfaced
Validated biomarker combination model for lung cancer detection, but retrospective single-center design limits impact.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.